Research’s Race to Stop a Pandemic

Should We Delay Lung Cancer Screening During the COVID-19 Pandemic?

Improving Molecular Testing in Lung Cancer: What We Learned From the IASLC Global Survey 

Statistical Design Flexibility Versus Optimism: The Example of KEYNOTE-604

Impactful Multidisciplinary Care Not Out of Reach in Community Settings

Adjusting Occupational and Physical Therapy Services for Patients With Lung Cancer During the COVID-19 Pandemic

CT Findings of COVID-19 Pneumonia and Mimicking Diseases in Patients With Lung Cancer

EGFR/ALK-Mutated NSCLC: Using Real-world Therapeutic Practices to Help Answer Real-world Therapeutic Questions

SBRT Versus Surgery in the COVID-19 Era: What Has Changed and What Hasn't?

Increasing Understanding about the Role Biosimilar Agents in Everyday Practice: A Q&A with Dr. Gary Lyman (Part 1 of 2) 

Osimertinib Approved as Adjuvant Therapy for NSCLC with Certain EGFR Mutations

Leora Horn, MD, MSc, FRCPC